[{"address1": "1185 Avenue of the Americas", "address2": "3rd Floor", "city": "New York", "state": "NY", "zip": "10036", "country": "United States", "phone": "973 242 0005", "website": "https://www.synaptogen.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. The company focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. It is also evaluating therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as fragile X syndrome, multiple sclerosis, and Niemann-pick type C disease. The company was incorporated in 2012 and is headquartered in New York, New York.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Alan J. Tuchman M.D., MBA(FAAN)", "age": 76, "title": "CEO & Director", "yearBorn": 1947, "fiscalYear": 2022, "totalPay": 374795, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Daniel L. Alkon M.D.", "age": 81, "title": "President, Chief Scientific Officer & Director", "yearBorn": 1942, "fiscalYear": 2022, "totalPay": 450000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert  Weinstein", "age": 63, "title": "CFO, Executive VP, Treasurer & Secretary", "yearBorn": 1960, "fiscalYear": 2022, "totalPay": 520883, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 4, "previousClose": 4.525, "open": 4.15, "dayLow": 4.15, "dayHigh": 5.35, "regularMarketPreviousClose": 4.525, "regularMarketOpen": 4.15, "regularMarketDayLow": 4.15, "regularMarketDayHigh": 5.35, "forwardPE": -3.0487194, "volume": 136886, "regularMarketVolume": 136886, "averageVolume": 34173, "averageVolume10days": 35037, "averageDailyVolume10Day": 35037, "marketCap": 5426541, "fiftyTwoWeekLow": 0.22, "fiftyTwoWeekHigh": 8.775, "fiftyDayAverage": 4.793313, "twoHundredDayAverage": 2.0926182, "currency": "USD", "enterpriseValue": 106800976, "floatShares": 26253957, "sharesOutstanding": 1085330, "sharesShort": 17063, "sharesShortPriorMonth": 19179, "sharesShortPreviousMonthDate": 1707955200, "dateShortInterest": 1710460800, "sharesPercentSharesOut": 0.0008, "heldPercentInsiders": 0.024349999, "heldPercentInstitutions": 0.039049998, "shortRatio": 0.4, "shortPercentOfFloat": 0.0008, "impliedSharesOutstanding": 20390800, "bookValue": 1.011, "priceToBook": 4.9454994, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -13779278, "trailingEps": -29.5, "forwardEps": -1.64, "lastSplitFactor": "1:25", "lastSplitDate": 1712275200, "enterpriseToEbitda": -12.856, "52WeekChange": 5.172716, "SandP52WeekChange": 0.26653707, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "SNPX", "underlyingSymbol": "SNPX", "shortName": "Synaptogenix, Inc.", "longName": "Synaptogenix, Inc.", "firstTradeDateEpochUtc": 1607437800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "d14ff140-0ac6-3af9-a386-f918dc6aa47f", "messageBoardId": "finmb_268943522", "gmtOffSetMilliseconds": -14400000, "currentPrice": 4.9999, "recommendationMean": 3.0, "recommendationKey": "hold", "totalCash": 30099998, "totalCashPerShare": 1.109, "ebitda": -8307507, "quickRatio": 7.039, "currentRatio": 7.14, "returnOnAssets": -0.14905, "returnOnEquity": -0.19799, "freeCashflow": -1554441, "operatingCashflow": -5173209, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-04-07"}]